Delivery Order SPE2DB22D2005-SPE2DB25FJQV6
- Not listed
- The Defense Logistics Agency awarded a $10,273.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Methylprednisolone 400 mg/5 mL injections, with an ultimate completion date of September 10, 2025. This non-set-aside competitive award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract specifies performance at the company's corporate office location in Conshohocken, Pennsylvania....
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at eleven thousand six hundred dollars against the Defense Logistics Agency Troop Support Medical indefinite delivery/indefinite quantity contract. The delivery order is to provide four milligram doses of the pharmaceutical methylprednisolone for use by the Department of Defense. Performance will occur at Amerisourcebergen's facility in...
- The Defense Logistics Agency Troop Support Medical awarded a $40,000 firm fixed price delivery order to Amerisourcebergen Drug Corp for methylprednisolone. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by July 9, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp. No subcontractors or set aside designations were identified. This delivery order...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The order is for 400 mg/5 ml methylprednisolone, a pharmaceutical product, with a ceiling value of $14,546.88. The contract is a firm fixed-price delivery order with a completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- Amerisourcebergen Drug Corporation has been awarded a $20,000 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply methylprednisolone at the prime contractor's facility located in Conshohocken, Pennsylvania. The single award is for product delivery by July 20, 2023 under DLA's indefinite-delivery/indefinite-quantity prime vendor medical supply contract vehicle. No subcontractors or set aside designations were identified. DLA manages the global...
- Amerisourcebergen Drug Corporation has been awarded a $50,000 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide methylprednisolone at the prime contractor's facility located in Conshohocken, Pennsylvania. The single delivery is scheduled to take place on July 20, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing indefinite-delivery/indefinite-quantity...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of methylprednisolone sodium, a pharmaceutical product. The contract is a firm fixed price delivery order with a ceiling value of $4,172.40 and a period of performance through March 29, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $1,265.88 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025, for the supply of Solu-Medrol 500 mg vials. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.83 on August 4, 2025, for the supply of Prednisolone 15 mg/5 ml Solution in a 480 ml quantity. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 17, 2025, for 500 tablets of Prednisone 20 mg, with a ceiling value of $1,190.10 and a completion date of September 18, 2025. This firm fixed-price contract, which involved no set-aside designation, represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQV6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,611.01 to AmerisourceBergen Drug Corp for the supply of Methylprednisolone 125 mg on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a child contract under the SPE2DX prime indefinite delivery vehicle, this delivery order represents routine pharmaceutical procurement supporting military and federal healthcare systems. AmerisourceBergen's extensive federal portfolio demonstrates its capability to supply a broad range of medications, medical devices, and healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. The DLA's continued reliance on AmerisourceBergen for pharmaceutical products reflects the company's established performance in meeting federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 8/4/25 |